Wilson Sonsini Goodrich & Rosati

company

About

Wilson Sonsini Goodrich & Rosati provides legal services for technology, life sciences, and other growth enterprises.

  • 1001 - 5000

Highlights

Details

Industries
Finance,FinTech,Intellectual Property,Privacy,Venture Capital
Founded date
Jan 1, 1961
Number Of Employee
1001 - 5000
Operating Status
Active

Wilson Sonsini Goodrich & Rosati is the premier legal advisor to technology, life sciences, and other growth enterprises worldwide. They represent companies at every stage of development, from entrepreneurial start-ups to multibillion-dollar global corporations, as well as the venture firms, private equity firms, and investment banks that finance and advise them. The firm's broad range of services and practice areas are focused on addressing the principal challenges faced by the management, boards of directors, shareholders, and in-house counsel of their clients.

The firm is nationally recognized for providing high-quality services to address the legal solutions required by its enterprise and financial institution clients. Their services include corporate law and governance, public and private offerings of equity and debt securities, mergers and acquisitions, securities class action litigation, intellectual property litigation, antitrust counseling and litigation, joint ventures and strategic alliances, technology licensing and other intellectual property transactions, tax, and employee benefits and employment law, among other areas. Their distinguished international roster of clients span a wide variety of industries, including information technology, life sciences, energy and clean technology, media and entertainment, communications, retail, and financial services.

Investments

Number of Investments
Number of Lead Investments
4
0
Wilson Sonsini Goodrich & Rosati has made 4 investments. Their most recent investment was on Dec 5, 2022, when SonoThera raised $60.75M.
Date Company Name
Round Money Raised Industry Lead Investor
Dec 5, 2022 SonoThera
Series A $60.75M Biopharma
Dec 31, 2020 Crowdz
Series A $4.01M B2B
Mar 31, 2013 Chat Sports
Seed $0.90M Apps
Aug 30, 2012 HireVue
Series C $17M Artificial Intelligence